Literature DB >> 6688965

Effect of temperature on the cytotoxicity of vindesine, amsacrine, and mitoxantrone.

T S Herman.   

Abstract

The effect of elevated temperature on the cytotoxicity of three new anticancer drugs (vindesine, mitoxantrone, and amsacrine [AMSA]) was tested in Chinese hamster ovary cells in vitro. Three distinct patterns of interaction with hyperthermia were observed. Vindesine, tested at 37 degrees C, produced a 50% cell kill when concentrations of greater than or equal to 1.0 micrograms/ml (up to 3.0 micrograms/ml) for 1 hour were used. At 42.4 degrees C, concentrations greater than 1.0 micrograms/ml for 1 hour caused a 60% cell kill (an additive cytotoxic effect). Mitoxantrone produced concentration-dependent lethality at 37 degrees C (89% cell kill after 0.25 micrograms/ml for 1 hour; 99% cell kill after 1.0 micrograms/ml for 1 hour). Exposure to mitoxantrone at 42.4 degrees C resulted in synergistic cytotoxicity (97% cell kill after 0.25 micrograms/ml for 1 hour; 99.98% cell kill after 1.0 micrograms/ml for 1 hour). In contrast, treatment with AMSA at 42.4 degrees C inhibited cytotoxicity (99.98% cell kill after 5 micrograms/ml for 1 hour at 37 degrees C; 91% cell kill after 5 micrograms/ml for 1 hour at 42.4 degrees C). AMSA was not inactivated after being heated at 42.4 degrees C for 1 hour prior to treatment of cells at 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688965

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  9 in total

1.  A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.

Authors:  Zeljko Vujaskovic; Dong W Kim; Ellen Jones; Lan Lan; Linda McCall; Mark W Dewhirst; Oana Craciunescu; Paul Stauffer; Vlayka Liotcheva; Allison Betof; Kimberly Blackwell
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 2.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 3.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 4.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

5.  Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.

Authors:  B A Teicher; S A Holden; V Khandakar; T S Herman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Clinical pharmacokinetics of mitoxantrone in hyperthermic, isolated perfusion of the leg.

Authors:  J D Nagel; I Krüger; F Ghussen; U Bode
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice.

Authors:  G Wiedemann; S Roszinski; A Biersack; C Weiss; T Wagner
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Local hyperthermic treatment does not enhance mitoxantrone effectiveness for responses of a rat solid tumour regrowing after irradiation.

Authors:  C van Bree; E M Schopman; P J Bakker; J B Kipp; G W Barendsen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 9.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.